Annual Long Term Debt
$43.66 M
-$2.22 M-4.83%
31 December 2022
Summary:
Mirati Therapeutics annual long term debt is currently $43.66 million, with the most recent change of -$2.22 million (-4.83%) on 31 December 2022. During the last 3 years, it has fallen by -$2.22 million (-4.83%).MRTX Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Long Term Debt
$42.20 M
-$519.00 K-1.21%
30 September 2023
Summary:
Mirati Therapeutics quarterly long term debt is currently $42.20 million, with the most recent change of -$519.00 thousand (-1.21%) on 30 September 2023.MRTX Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
MRTX Long Term Debt Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -4.8% | -8.0% |
| 5 y5 years | +100.0% | +100.0% |
MRTX Long Term Debt High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -4.8% | -8.0% |
Mirati Therapeutics Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $42.20 M(-1.2%) |
| June 2023 | - | $42.72 M(-1.2%) |
| Mar 2023 | - | $43.23 M(-1.0%) |
| Dec 2022 | $43.66 M(-4.8%) | $43.66 M(-1.0%) |
| Sept 2022 | - | $44.09 M(-3.8%) |
| June 2022 | - | $45.82 M(-0.0%) |
| Mar 2022 | - | $45.83 M(-0.1%) |
| Dec 2021 | $45.88 M(+9.5%) | $45.88 M(+0.8%) |
| Sept 2021 | - | $45.52 M(+2.3%) |
| June 2021 | - | $44.48 M(+3.0%) |
| Mar 2021 | - | $43.17 M(+3.0%) |
| Dec 2020 | $41.91 M(>+9900.0%) | $41.91 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2019 | $0.00(-100.0%) | $0.00(-100.0%) |
| Sept 2010 | - | $228.70 K(-29.8%) |
| Mar 2010 | - | $325.70 K(-10.3%) |
| Dec 2009 | $362.90 K(+10.7%) | $362.90 K(-85.7%) |
| Sept 2009 | - | $2.53 M(+1.7%) |
| June 2009 | - | $2.49 M(+2.3%) |
| Mar 2009 | - | $2.43 M(+642.5%) |
| Dec 2008 | $327.90 K(-38.0%) | $327.90 K(-38.0%) |
| Dec 2007 | $529.10 K(+9698.1%) | $529.10 K(>+9900.0%) |
| June 2005 | - | $800.00(-68.0%) |
| Mar 2005 | - | $2500.00 |
| Dec 2004 | $5400.00(-73.8%) | - |
| Dec 2003 | $20.60 K | - |
FAQ
- What is Mirati Therapeutics annual long term debt?
- What is the all time high annual long term debt for Mirati Therapeutics?
- What is Mirati Therapeutics quarterly long term debt?
- What is the all time high quarterly long term debt for Mirati Therapeutics?
What is Mirati Therapeutics annual long term debt?
The current annual long term debt of MRTX is $43.66 M
What is the all time high annual long term debt for Mirati Therapeutics?
Mirati Therapeutics all-time high annual long term debt is $45.88 M
What is Mirati Therapeutics quarterly long term debt?
The current quarterly long term debt of MRTX is $42.20 M
What is the all time high quarterly long term debt for Mirati Therapeutics?
Mirati Therapeutics all-time high quarterly long term debt is $45.88 M